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Editorial
Thinking Big: Four Ways to Advance
Environmental Health Research to
Answer the Needs of Public Policy
Environmental health research has reached a juncture where
tremendous opportunities lie ahead, ifwe but have the leadership to
move our many disciplines forward-and the vision and courage to
think big. The hard work of the past 30 years has developed our
skills and our tools to a point where we can advance the very con-
cept ofwhat environmental research is all about-if we but dare to
commit to the adventure-if we have the sense and seize the
resources to make what we imagine real.
I envision four major efforts: 1) to map the "environmental
genome," to analyze the blood ofenough Americans to determine
the variations in some 200 susceptibility genes; 2) to determine, in
a large-scale survey with testing, what major chemicals a large repre-
sentative sampling of Americans have been exposed to and carry
around in their blood; 3) to address, at last, the problem of mix-
tures-the problems ofthe real world; and 4) to develop and put in
place faster, better testing using transgenic mice and other innovative
methods.
We know that, in the past, Congress and the American people
have been rightly critical of a process in which costly environmental
health regulatory policies have had to be developed without ade-
quate information. Too often, there is too little scientifically sound
information on which to base many decisions. When there is too
little information, there are opportunities for lobbyists on one side
to posit that further regulation will end outdoor barbecues and
campfires, while the other side paints an apocalypse if regulations
are not immediately put into place. Indeed, without more basic
data there can be no satisfactory solution to the complex issues sur-
rounding human exposure to environmental pollutants and health
outcomes. We may find ourselves overregulating, at a cost to our
economy, to avoid risking underregulation, with potential harm to
health. But without better information, we cannot make the best
decisions-ones that provide full health protection at the most rea-
sonable cost.
This problem of too little information is highlighted in the
news media almost on a daily basis. The most current example is
the GulfWar veterans illness-a situation in which there is too lit-
tle information about individual differences in susceptibility, too
little information about the health effects ofmixtures, and too little
information about multiple, chemical sensitivity, chronic fatigue
syndrome, and fibromyalgia.
Likewise, there is too little information on the health effects of
exposure to environmental estrogens to develop public policy in
which the American people can have confidence. Both the EPA and
industry groups acknowledge that more research is needed on the
health effects ofhuman exposure to ozone and particulate matter in
the air we breathe.
To compensate for lack ofscientific information, environmental
health protection policy is often
based on broad and expensive
programs of environmental - I remediation, controls, regula-
tions, and public education. This question of cost of intervention
versus benefit leaves both Congress and the public in the uncom-
fortable position, particularly in times ofscarce resources, ofhaving
to decide whether to relax environmental controls and appear uncar-
ing or to continue to spend large sums ofmoney on programs whose
impact on public health is uncertain.
In the face of considerable challenge and public criticism, one
can either dig in and defend the status quo or one can face the facts
and lead and embrace the change. My beliefis that the status quo is
no longer defensible and that, since we now have the tools and the
skills, we should vigorously lead an effort to ensure that the research
is done to improve environmental health decision making.
I envision investment in four critical areas of science where
major information gaps exist, areas where reasonable research ques-
tions can be formulated, areas where technologies are available, areas
where understanding offers the potential to significantly improve
public health and regulatory policy.
First, research is urgently needed to determine the basis for the
wide variation in individual responsiveness to exposures to environ-
mental toxicants. There are differences in responsiveness, or suscep-
tibility, differences in past and present exposures to related and
unrelated toxicants, and differences related to age, gender, lifestyle,
or genetic predisposition; yet these are rarely taken into considera-
tion in assessing human risk because the database is not available.
To address this problem, the NIEHS proposes to expand its molecu-
lar genetics research to identify susceptibility genes for environmen-
tally induced diseases through a new Environmental Genome
Project.
This genome project will be a broad multicenter effort to obtain
information about DNA sequence diversity for the U.S. population
on all of the environmental disease susceptibility genes now recog-
nized (more than 200).
Second, there is an urgent need to develop new approaches to
toxicological testing to cut costs and increase timeliness. Using the
current methodologies, it takes approximately five years to evaluate a
chemical for carcinogenicity at a cost oftwo to six million dollars. If
we are going to work ourway through the thousands ofchemicals to
which humans are exposed, we must develop bold new screening
strategies. There are new high-throughput screening assays that
promise to be less costly, more relevant to predicting human risks,
and timelier in generating the information (in ayear or less).
Third, investigation ofthe mechanisms and health effects ofmix-
tures is another area where lack ofinformation is a serious problem.
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The current toxicologic databases were developed using single
chemicals in animal bioassays.
As we all know, humans are exposed to a variety of chemicals,
either concurrently or sequentially at different doses via multiple
pathways. The problem of mixtures is not limited to interactions
between chemicals because health outcomes ofexposure to chemical
agents can also be influenced by the simultaneous exposure to phys-
ical and biological agents.
For example, the risk ofradon-induced lung cancer is increased
in cigarette smokers, and people infected with hepatitis B virus are
more susceptible to aflatoxin-induced liver cancer. Thus, our inabil-
ity to say whether agents act in an additive, synergistic, or antago-
nistic fashion creates real problems in health risk assessment.
Depending on the assumptions made regarding the nature of
the interaction between components, risk may be seriously over- or
underestimated with dire economic or public health consequences,
respectively.
Fourth and last is the major challenge ofstrengthening the links
between fundamental science, toxicology, epidemiology, and public
health. We can make environmental health research findings more
applicable to human risk assessment by determining the actual
range ofhuman exposure to specific chemicals.
We can now measure many of these chemicals in body tissues
such as blood and urine. As a top priority, using improved and high-
ly sensitive analytical procedures, we should expand the National
Health and Nutrition Exposures Survey coordinated by the
National Center for Health Statistics to monitor the exposure ofthe
U.S. population to the chemicals listed in the National Toxicology
Program's Biennial Report on Carcinogens.
Such "real world" exposure assessment would be far more useful
than estimation ofexposure based on the EPA toxic release and pro-
duction information, as is currently done. Also, the current
approach does not take into account the biologically effective dose
and individual or species/group differences in the uptake and
metabolism ofvarious chemicals.
Estimation of exposure based on toxic release and production
information is, at best, only a reflection ofthe potential for human
exposure.
The public health component of the above goals can best be
achieved through NIEHS partnerships with the CDC and the EPA.
Our ongoing partnership with the CDC on exposure assessment
could be expanded, and new ones with the EPA are under discus-
sion.
Progress in the four areas ofresearch offers "real world" answers
to the quagmire ofindecision and discontent that is a consequence
of having too little information. And, best of all, our vision of a
more science-based environmental health regulatory decision-mak-
ing system is achievable, given today's technologies.
Let's put the uncertainties and public debates about environ-
mental health policies to rest with science. Let's join the chorus call-
ing for "sound science," and let's insist on the resources to do the
job. We can pull together and focus some resources ourselves, but
we must also insist that policy makers who call for "sound science"
appropriate the resources to generate the science.
Kenneth Olden
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